AlzeCure Pharma to present at Redeye Neurology Day
AlzeCure Pharma will attend Redeye Neurology Day in Stockholm on Oct. 15, 2026, where CEO Martin Jönsson will present an update on outlicensing agreements with Eli Lilly and QuantumCell.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.